Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis

Multiple Sclerosis

Volumn 7, Issue 5, 2001, Pages 285-289

  Egg, R ^a   Reindl, M ^a   Deisenhammer, F ^a   Linington, C ^a   Berger, T ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

IgA; IgG subclass; IgM; Immunoglobulin; Myelin basic protein; Myelin oligodendrocyte glycoprotein

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERFERON BETA SERINE; METHOTREXATE; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ARTICLE; AUTOIMMUNE DISEASE; DISEASE COURSE; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RELAPSE;

ADULT; AUTOANTIBODIES; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN;

EID: 0034751391     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245801681137979     Document Type: Article

References (40)

1. Patterns of oligodendroglia pathology in multiple sclerosis
2. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology of the University of Vienna
3. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
4. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
5. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
6. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease
7. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
8. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system
9. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein
10. Myelin/oligodentrocyte glycoprotein is a unique member of the immunoglobulin superfamily
11. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
12. Investigation of myelin/oligodendrocyte glycoprotein membrane topology
13. Identification of autoantibodies associated with myelin damage in multiple sclerosis
14. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study
15. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis
16. Determination of IgG subclass antibodies to the basic myelin protein in patients with multiple sclerosis
17. Antibody to myelin basic protein in extracts of multiple sclerosis brain
18. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
19. Defining the clinical course of multiple sclerosis
20. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
21. Molecular mimicry in T cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
22. Antibody response in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG)
23. Antibody facilitation of multiple sclerosis-like lesions in a non human primate
24. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis
25. Immunoblot detection of oligoclonal antimyelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis
26. B cells and autoimmunity
27. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
28. Determinant spreading and the dynamics of the autoimmune T-cell repertoire
29. Epitope spreading
30. Diversity and plasticity of self-recognition during the development of multiple sclerosis
31. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis
32. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study
33. The human IgA system: A reassessment
34. Primary progressive multiple sclerosis: A distinct syndrome?
35. IgG subclasses of antibodies in systemic lupus erythematosus, Sjögren's syndrome, and drug induced autoimmunity
36. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA and IgG rheumatoid factor
37. IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in SLE
38. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
39. Interferon beta induces T-helper 2 immune deviation in MS